product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
Peripheral Node Addressin Antibody (MECA-79R) - BSA Free
catalog :
NBP2-78792
quantity :
0.5 mg (also 0.1 mg)
price :
479 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
MECA-79R
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 47
Reference
Gavish A, Tyler M, Greenwald A, Hoefflin R, Simkin D, Tschernichovsky R, et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature. 2023;618:598-606 pubmed publisher
Park J, Espinosa Cotton M, Guo H, Monette S, Cheung N. Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. J Immunother Cancer. 2023;11: pubmed publisher
Quigley L, Pang L, Tavancheh E, Ernst M, Behren A, Huynh J, et al. Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistry. STAR Protoc. 2023;4:101961 pubmed publisher
Zhao J, Jung S, Li X, Li L, Kasinath V, Zhang H, et al. Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice. J Clin Invest. 2022;132: pubmed publisher
Smith K, Minns D, McHugh B, Holloway R, O CONNOR R, Williams A, et al. The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biol. 2022;20:e3001554 pubmed publisher
Li Y, Amaladas N, O Mahony M, Manro J, Inigo I, Li Q, et al. Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models. PLoS ONE. 2022;17:e0268244 pubmed publisher
Pinkard H, Baghdassarian H, Mujal A, Roberts E, Hu K, Friedman D, et al. Learned adaptive multiphoton illumination microscopy for large-scale immune response imaging. Nat Commun. 2021;12:1916 pubmed publisher
Li X, Zhao J, Kasinath V, Uehara M, Jiang L, Banouni N, et al. Lymph node fibroblastic reticular cells deposit fibrosis-associated collagen following organ transplantation. J Clin Invest. 2020;130:4182-4194 pubmed publisher
Deng M, Tam J, Wang L, Liang K, Li S, Zhang L, et al. TRAF3IP3 negatively regulates cytosolic RNA induced anti-viral signaling by promoting TBK1 K48 ubiquitination. Nat Commun. 2020;11:2193 pubmed publisher
Shi D, Chen M, Liu L, Wang Q, Liu S, Wang L, et al. Anti-influenza A virus mechanism of three representative compounds from Flos Trollii via TLRs signaling pathways. J Ethnopharmacol. 2020;253:112634 pubmed publisher
He B, Johansson Percival A, Backhouse J, Li J, Lee G, Hamzah J, et al. Remodeling of Metastatic Vasculature Reduces Lung Colonization and Sensitizes Overt Metastases to Immunotherapy. Cell Rep. 2020;30:714-724.e5 pubmed publisher
Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
van Tol S, Atkins C, Bharaj P, Johnson K, Hage A, Freiberg A, et al. VAMP8 Contributes to the TRIM6-Mediated Type I Interferon Antiviral Response during West Nile Virus Infection. J Virol. 2020;94: pubmed publisher
Matsubara S, Seki M, Suzuki S, Komori T, Takamori M. Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors. J Immunother Cancer. 2019;7:256 pubmed publisher
Li X, Bean A, Uehara M, Banouni N, Ben Nasr M, Kasinath V, et al. Immune heterogeneity of head and tail pancreatic lymph nodes in non-obese diabetic mice. Sci Rep. 2019;9:9778 pubmed publisher
Uehara M, Li X, Sheikhi A, Zandi N, Walker B, Saleh B, et al. Anti-IL-6 eluting immunomodulatory biomaterials prolong skin allograft survival. Sci Rep. 2019;9:6535 pubmed publisher
Bahmani B, Uehara M, Ordikhani F, Li X, Jiang L, Banouni N, et al. Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery. EBioMedicine. 2018;38:79-88 pubmed publisher
Bahmani B, Uehara M, Jiang L, Ordikhani F, Banouni N, Ichimura T, et al. Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival. J Clin Invest. 2018;128:4770-4786 pubmed publisher
Wuerth J, Habjan M, Wulle J, Superti Furga G, Pichlmair A, Weber F. NSs protein of Sandfly fever Sicilian phlebovirus counteracts interferon induction by masking the DNA-binding domain of interferon regulatory factor 3. J Virol. 2018;: pubmed publisher
Gulen M, Koch U, Haag S, Schüler F, Apetoh L, Villunger A, et al. Signalling strength determines proapoptotic functions of STING. Nat Commun. 2017;8:427 pubmed publisher
Kwon D, Park E, Sesaki H, Kang S. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) suppresses STING-mediated DNA sensing pathway through inducing mitochondrial fission. Biochem Biophys Res Commun. 2017;493:737-743 pubmed publisher
Slowicka K, Vereecke L, Mc Guire C, Sze M, Maelfait J, Kolpe A, et al. Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling. Eur J Immunol. 2016;46:971-80 pubmed publisher
Mukawera E, Chartier S, Williams V, Pagano P, Lapointe R, Grandvaux N. Redox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell lines. Redox Biol. 2015;6:9-18 pubmed publisher
Hautz T, Zelger B, Nasr I, Mundinger G, Barth R, Rodriguez E, et al. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts. Transpl Int. 2014;27:966-76 pubmed publisher
Yu H, Croxen M, Marchiando A, Ferreira R, Cadwell K, Foster L, et al. Autophagy facilitates Salmonella replication in HeLa cells. MBio. 2014;5:e00865-14 pubmed publisher
Conlon J, Burdette D, Sharma S, Bhat N, Thompson M, Jiang Z, et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol. 2013;190:5216-25 pubmed publisher
Tamassia N, Bazzoni F, Le Moigne V, Calzetti F, Masala C, Grisendi G, et al. IFN-? expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling. J Immunol. 2012;189:1500-9 pubmed publisher
Delhase M, Kim S, Lee H, Naiki Ito A, Chen Y, Ahn E, et al. TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2. Proc Natl Acad Sci U S A. 2012;109:E177-86 pubmed publisher
Ogasawara N, Sasaki M, Itoh Y, Tokudome K, Kondo Y, Ito Y, et al. Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction. J Clin Biochem Nutr. 2011;48:154-60 pubmed publisher
Joung S, Park Z, Rani S, Takeuchi O, Akira S, Lee J. Akt contributes to activation of the TRIF-dependent signaling pathways of TLRs by interacting with TANK-binding kinase 1. J Immunol. 2011;186:499-507 pubmed publisher
Hirakawa J, Tsuboi K, Sato K, Kobayashi M, Watanabe S, Takakura A, et al. Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing. J Biol Chem. 2010;285:40864-78 pubmed publisher
Marchlik E, Thakker P, Carlson T, Jiang Z, Ryan M, Marusic S, et al. Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality. J Leukoc Biol. 2010;88:1171-80 pubmed publisher
Berthet J, Damien P, Hamzeh Cognasse H, Pozzetto B, Garraud O, Cognasse F. Toll-like receptor 4 signal transduction in platelets: novel pathways. Br J Haematol. 2010;151:89-92 pubmed publisher
Tamassia N, Le Moigne V, Rossato M, Donini M, McCartney S, Calzetti F, et al. Activation of an immunoregulatory and antiviral gene expression program in poly(I:C)-transfected human neutrophils. J Immunol. 2008;181:6563-73 pubmed
Radtke A, O Riordan M. Homeostatic maintenance of pathogen-containing vacuoles requires TBK1-dependent regulation of aquaporin-1. Cell Microbiol. 2008;10:2197-207 pubmed publisher
McCoy C, Carpenter S, Palsson McDermott E, Gearing L, O Neill L. Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation. J Biol Chem. 2008;283:14277-85 pubmed publisher
Burke S, Dong H, Hazan A, Croy B. Aberrant endometrial features of pregnancy in diabetic NOD mice. Diabetes. 2007;56:2919-26 pubmed
Tamassia N, Le Moigne V, Calzetti F, Donini M, Gasperini S, Ear T, et al. The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J Immunol. 2007;178:7344-56 pubmed
Merimi M, Klener P, Szynal M, Cleuter Y, Kerkhofs P, Burny A, et al. Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code. J Virol. 2007;81:5929-39 pubmed
Péant B, Diallo J, Lessard L, Delvoye N, Le Page C, Saad F, et al. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Mol Cancer Res. 2007;5:87-94 pubmed
Aksoy E, Albarani V, Nguyen M, Laes J, Ruelle J, De Wit D, et al. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood. 2007;109:2887-93 pubmed
Sankar S, Chan H, Romanow W, Li J, Bates R. IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines. Cell Signal. 2006;18:982-93 pubmed
Osterlund P, Veckman V, Sirén J, Klucher K, Hiscott J, Matikainen S, et al. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol. 2005;79:9608-17 pubmed
Drayton D, Ying X, Lee J, Lesslauer W, Ruddle N. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J Exp Med. 2003;197:1153-63 pubmed
Fitzgerald K, McWhirter S, Faia K, Rowe D, Latz E, Golenbock D, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003;4:491-6 pubmed
Samulowitz U, Kuhn A, Brachtendorf G, Nawroth R, Braun A, Bankfalvi A, et al. Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope. Am J Pathol. 2002;160:1669-81 pubmed
Csencsits K, Jutila M, Pascual D. Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site. J Immunol. 1999;163:1382-9 pubmed
product information
master code :
NBP2-78792
SKU :
NBP2-78792
product name :
Peripheral Node Addressin Antibody (MECA-79R) - BSA Free
unit size :
0.5 mg (also 0.1 mg)
description :
The Peripheral Node Addressin Antibody (MECA-79R) - BSA Free from Novus is a rat monoclonal antibody to Peripheral Node Addressin. This antibody reacts with human,mouse. The Peripheral Node Addressin Antibody (MECA-79R) - BSA Free has been validated for the following applications: Multiplex Immunofluorescence,Immunohistochemistry,Immunocytochemistry/ Immunofluorescence,IF/IHC,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,In vivo assay,Multiplex Immunoassay,Western Blot.
target :
Peripheral Node Addressin
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
MECA-79R
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Rat
immunogen :
Mouse lymph node stromal cells
isotype :
IgG1
purity :
Protein A or G purified
species :
Human,Mouse
applications :
Multiplex Immunofluorescence,Immunohistochemistry,Immunocytochemistry/ Immunofluorescence,IF/IHC,Immunohistochemistry-Paraffin,Immunohistochemistry-Frozen,In vivo assay,Multiplex Immunoassay,Western Blot
USD :
479 USD
alt names :
MECA-79, Peripheral Node Addressin, PNAd
storage :
Store at -20 ░C.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.